Federation Bio Overview
- Year Founded
-
2018
- Status
-
Out of Business
- Employees
-
35
- Latest Deal Type
-
Out of Business
- Investors
-
1
Federation Bio General Information
Description
Developer of microbiome-based therapeutics designed to combat and reverse serious diseases. The company's microbial approach leverages naturally occurring bacteria along with a diverse community of supportive bacteria to drive engraftment and durable therapeutic responses, enabling medical professionals to optimize outcomes related to a diverse set of conditions ranging from metabolic disorders and cholestatic diseases to cancer and autoimmune conditions.
Contact Information
Website
www.federation.bioCorporate Office
- 300 Utah Avenue
- Suite 100
- South San Francisco, CA 94080-6805
- United States
Corporate Office
- 300 Utah Avenue
- Suite 100
- South San Francisco, CA 94080-6805
- United States
Federation Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 11-Oct-2023 | Completed | Out of Business | |||
| 2. Early Stage VC (Series A) | 06-Oct-2020 | Completed | Startup | |||
| 1. Seed Round | 11-Dec-2018 | $6M | $6M | Completed | Startup |
Federation Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
Federation Bio Comparisons
Industry
Financing
Details
Federation Bio Competitors (3)
One of Federation Bio’s 3 competitors is Siolta Therapeutics, a Venture Capital-Backed company based in San Carlos, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Siolta Therapeutics | Venture Capital-Backed | San Carlos, CA | ||||
| Seres Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Allena Pharmaceuticals | Formerly VC-backed | Newton, MA |
Federation Bio Patents
Federation Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023102091-A2 | Microbial consortia | Inactive | 01-Dec-2021 | ||
| WO-2023102091-A3 | Microbial consortia | Inactive | 01-Dec-2021 | ||
| EP-4152959-A1 | High-complexity synthetic gut bacterial communities | Pending | 21-May-2020 | ||
| EP-4152959-A4 | High-complexity synthetic gut bacterial communities | Pending | 21-May-2020 | ||
| WO-2021237162-A1 | High-complexity synthetic gut bacterial communities | Inactive | 21-May-2020 | A23L33/10 |
Federation Bio Signals
Federation Bio Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Open Field Capital | Venture Capital | Minority |
Federation Bio FAQs
-
When was Federation Bio founded?
Federation Bio was founded in 2018.
-
Where is Federation Bio headquartered?
Federation Bio is headquartered in South San Francisco, CA.
-
What is the size of Federation Bio?
Federation Bio has 35 total employees.
-
What industry is Federation Bio in?
Federation Bio’s primary industry is Drug Discovery.
-
Is Federation Bio a private or public company?
Federation Bio is a Private company.
-
What is Federation Bio’s current revenue?
The current revenue for Federation Bio is .
-
How much funding has Federation Bio raised over time?
Federation Bio has raised $56M.
-
Who are Federation Bio’s investors?
Open Field Capital has invested in Federation Bio.
-
Who are Federation Bio’s competitors?
Siolta Therapeutics, Seres Therapeutics, and Allena Pharmaceuticals are competitors of Federation Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process